LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 25.62 | 770.25 | 2458 | 2514 | 0.9774 | 0.9734 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 25.62 | 770.25 | 2138 | 2514 | 0.8501 | 0.8186 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 27.84 | 770.25 | 2737 | 2833 | 0.9658 | 0.9633 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 27.84 | 770.25 | 2388 | 2833 | 0.8427 | 0.8259 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 30.06 | 770.25 | 3070 | 3106 | 0.9884 | 0.9884 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 30.06 | 770.25 | 2660 | 3106 | 0.8564 | 0.8516 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 32.28 | 770.25 | 3338 | 3392 | 0.9838 | 0.9848 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 32.28 | 770.25 | 2890 | 3392 | 0.8518 | 0.8555 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 34.50 | 770.25 | 3564 | 3712 | 0.9601 | 0.9645 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 34.50 | 770.25 | 3084 | 3712 | 0.8308 | 0.8431 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 36.73 | 770.25 | 3915 | 4086 | 0.9581 | 0.9648 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 36.73 | 770.25 | 3396 | 4086 | 0.8311 | 0.8521 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 38.95 | 770.25 | 4331 | 4543 | 0.9532 | 0.9629 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 38.95 | 770.25 | 3665 | 4543 | 0.8066 | 0.8390 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 41.17 | 770.25 | 4743 | 5010 | 0.9466 | 0.9598 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 41.17 | 770.25 | 4045 | 5010 | 0.8073 | 0.8476 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 43.39 | 770.25 | 5170 | 5404 | 0.9566 | 0.9687 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 43.39 | 770.25 | 4444 | 5404 | 0.8223 | 0.8655 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 45.61 | 770.25 | 5576 | 5813 | 0.9592 | 0.9717 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 45.61 | 770.25 | 4754 | 5813 | 0.8178 | 0.8667 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 47.83 | 770.25 | 5925 | 6223 | 0.9520 | 0.9677 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 47.83 | 770.25 | 5076 | 6223 | 0.8156 | 0.8692 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 50.05 | 770.25 | 6287 | 6629 | 0.9483 | 0.9661 | MN20160304_L02 | C12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 50.05 | 770.25 | 5403 | 6629 | 0.8150 | 0.8725 | MN20160304_L02 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 52.27 | 770.25 | 6673 | 7058 | 0.9453 | 0.9651 | MN20160304_L02 | C12 |